20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Annexon, Inc. - common stock (ANNX) operates in the NASDAQ industry and is headquartered in Brisbane, United States with about 92 employees. Its market capitalization is roughly $785 million. In the fiscal year ended 2025-12-31, ANNX reported $0M in revenue and ($207M) in net income.
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.
Interactive charts & full statements →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | — |
| Gross Profit | — | ($4M) | ($3M) | ($3M) | ($3M) | ($3M) | ($1M) | $0M | $0M | $0M |
| Gross Margin % | — | — | — | — | — | — | — | — | — | — |
| Operating Income (EBIT) | ($211M) | ($216M) | ($154M) | ($144M) | ($146M) | ($131M) | ($63M) | ($33M) | ($19M) | ($20M) |
| Operating Margin % | — | — | — | — | — | — | — | — | — | — |
| Net Income | ($203M) | ($207M) | ($138M) | ($134M) | ($138M) | ($128M) | ($63M) | ($37M) | ($18M) | ($19M) |
| Net Margin % | — | — | — | — | — | — | — | — | — | — |
| EBITDA | ($200M) | ($204M) | ($135M) | ($132M) | ($143M) | ($129M) | ($63M) | ($32M) | ($19M) | ($20M) |
| Earnings Per Share (EPS) | $-1.18 | $-1.33 | $-1.01 | $-1.77 | $-2.53 | $-3.34 | $-3.70 | $-0.97 | $-1.60 | $-0.49 |
| Shares Outstanding (M) | 201M | 155M | 137M | 76M | 55M | 38M | 17M | 38M | 11M | 38M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | $0M | $3M | $0M |
| Gross Profit | — | ($1M) | ($1M) | — | ($1M) | ($1M) | $2M | ($1M) |
| Gross Margin % | — | — | — | — | — | — | 50.0% | — |
| Operating Income (EBIT) | ($57M) | ($46M) | ($50M) | ($57M) | ($52M) | ($57M) | ($52M) | ($39M) |
| Operating Margin % | — | — | — | — | — | — | -1541.7% | — |
| Net Income | ($55M) | ($44M) | ($48M) | ($55M) | ($49M) | ($54M) | ($49M) | ($35M) |
| Net Margin % | — | — | — | — | — | — | -1427.4% | — |
| EBITDA | ($55M) | ($43M) | ($47M) | ($54M) | ($49M) | ($54M) | ($48M) | ($34M) |
| Earnings Per Share (EPS) | $-0.28 | $-0.23 | $-0.31 | $-0.37 | $-0.33 | $-0.37 | $-0.33 | $-0.25 |
| Shares Outstanding (M) | 201M | 194M | 155M | 149M | 148M | 148M | 148M | 140M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($193M) | ($186M) | ($118M) | ($121M) | ($116M) | ($106M) | ($53M) | ($28M) | ($17M) | ($19M) |
| Capital Expenditures (CapEx) | $0M | $0M | $0M | $0M | $7M | $2M | $0M | $0M | $0M | $1M |
| Free Cash Flow (FCF) | ($193M) | ($186M) | ($118M) | ($121M) | ($123M) | ($108M) | ($54M) | ($29M) | ($17M) | ($20M) |
| FCF Margin % | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | $2M | — | — | — | — | $103M | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($48M) | ($47M) | ($46M) | ($52M) | ($38M) | ($50M) | ($36M) | ($32M) |
| Capital Expenditures (CapEx) | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Free Cash Flow (FCF) | ($48M) | ($47M) | ($46M) | ($52M) | ($38M) | ($50M) | ($36M) | ($32M) |
| FCF Margin % | — | — | — | — | — | — | -1058.2% | — |
| Dividends Paid | — | — | $2M | — | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $246M | $278M | $350M | $298M | $285M | $287M | $356M | $50M | $48M | $8M |
| Cash & Cash Equivalents | $199M | $162M | $49M | $225M | $140M | $75M | $269M | $44M | $44M | $3M |
| Total Liabilities | $60M | $66M | $57M | $47M | $54M | $55M | $12M | $6M | $10M | $54M |
| Total Debt (Short + Long-Term) | $3M | $3M | $3M | $2M | $1M | $1M | $0M | $0M | $0M | $0M |
| Total Shareholders' Equity | $186M | $212M | $293M | $251M | $231M | $232M | $344M | $44M | $38M | ($46M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ANNX viewer.
About TickerBase · Data methodology & sources · Privacy · Terms